Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Diabetes Treatment. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104152505A details enzymatic production of 4-HIL. Offers high yield and scalable supply chain solutions for diabetes treatment intermediates.
Patent CN103555683B reveals high-purity saxagliptin intermediate synthesis via PDH mutant. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel GLP-1 analogues with extended half-life via microwave solid-phase synthesis. Stable, high-purity pharmaceutical intermediates for diabetes treatment.
Patent CN101952252A details a tartaric acid resolution method for high-purity piperidine intermediates, offering significant cost reduction in API manufacturing and supply chain reliability.
Patent CN117003758A details enzymatic route for Sitagliptin. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel activation-condensation route for Sitagliptin intermediates. High yield, industrial scalability, cost-effective alternative to HOBt/EDC methods.
High-yield microbial conversion method for D-chiro-inositol from myo-inositol. Scalable fermentation process offering cost reduction and supply reliability.
Patent CN108866021B details a novel transaminase mutant for synthesizing sitagliptin intermediates with >99% ee. Discover cost-effective biocatalytic solutions for API manufacturing.
Patent CN113801903B reveals enzymatic route for sitagliptin intermediate offering high purity and supply chain stability for global API manufacturers.